A phase II multicenter study of neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) chemotherapy with pegfilgrastim support in patients (pts) muscle-invasive urothelial cancer (MIUC): Safety, pathologic, radiologic, and molecular correlates.
暂无分享,去创建一个
S. Signoretti | G. Bubley | G. Steele | J. Rosenberg | M. Hirsch | L. Appleman | E. Stack | K. Krajewski | M. Taplin | A. Qu | C. Sweeney | A. Elfiky | R. Ross | S. Jacobus | C. Tretter | Meghara Walsh | Rachel S. Park